User login
Language
Anonymous's groups in this site
User is not a member of any group.
Your groups across all your sites
User is not a member of any group.
Recent Content
Recent Comments
- Update: Biden announced vaccine doses and cash for Africa 1 month 1 week ago
- WHO's authorization of mpox vaccine should ease global access 1 month 3 weeks ago
- Ten symptoms of long COVID in children 2 months 1 week ago
- WHO seeks mpox vaccine production surge 2 months 2 weeks ago
Who's online
There are currently 0 users online.
You are here
AFP April 9, 2015
Tokyo A Japanese research team said on Thursday it had developed a field test for Ebola that gives results in just over 11 minutes -- down from the 90-minute test used now.
The breakthrough by Nagasaki University's Institute of Tropical Medicine will allow medics to move much more quickly in treating people with the haemorrhagic fever, Professor Jiro Yasuda told AFP.
"The result time was unexpectedly short," said Yasuda of the trial conducted in Guinea last month on 100 samples, of which 47 proved positive.
The Guinean government has now asked the institute and its collaboration partner Toshiba to supply equipment to roll out the test, he added.
Read complete story.
http://news.yahoo.com/japanese-ebola-test-gives-results-11-minutes-researcher-064839139.html
Comments
Study - Toshiba's Ebola Test Gives Results in Around 11 Minutes
firstwordmedtech.com - by Katie Bell - April 9, 2015
An Ebola test developed jointly by Toshiba and Nagasaki University provides results in just over 11 minutes, compared to the 90-minute polymerase chain reaction test currently used, the parties said. Researcher Jiro Yasuda from Nagasaki University's Institute of Tropical Medicine remarked that "the result time was unexpectedly short." . . .
. . . Yasuda further noted the Guinean government asked the institute and Toshiba to supply equipment to launch the test, adding that he hoped the new reagent would be used in Ebola-affected areas as soon as possible.
Current tests for Ebola include Corgenix Medical's ReEBOV Antigen Rapid Test, which has received approval from the World Health Organization, and Roche's LightMix Ebola Zaire rRT-PCR Test, which has been granted FDA emergency use authorisation. Meanwhile, bioMérieux's BioFire Defense's FilmArray Ebola test, called the BioThreat-E test, has also received emergency use authorisation from the FDA.
(READ COMPLETE ARTICLE)
(CLICK HERE - Jiro Yasuda)
(CLICK HERE - Nagasaki University - Department of Emerging Infectious Diseases)
(ALSO SEE RELATED INFORMATION HERE)